Liver disease due to hepatitis C virus (HCV) infection is an important cause of morbidity in patients on dialysis and in transplant recipients. This proposal will examine several factors related to HCV disease: 1) The effect of pre- transplantation infection on the prevalence and severity of liver disease, graft and patient survival will be studied in renal transplant recipients. 2) The prevalence and severity of liver disease in patients infected with HCV who continue on dialysis will be compared with those who undergo renal transplantation. 3) The prevalence and subtypes of HCV infection among cadaver organ donors in different parts of the country and their impact on tests for screening of these donors and transmission of infection will be studied. 4) The safety of using organs from HCV-infected donors in recipients with pre-transplantation HCV infection or in unselected recipients will be examined. 5) The factors that influence the prevalence and incidence of HCV infection in hemodialysis units and the impact of dialysis room and dialyzer reuse strategies to control the transmission of HCV infection in the dialysis units will be explored. 6) The performance of different screening and confirmatory tests in identifying current HCV infection among dialysis and transplant patients will be evaluated. The results of these studies are expected to have a broad impact on transplantation policies concerning donor and recipient selection with regard to hepatitis C infection, and on dialysis room policies to retard the transmission of HCV within dialysis units.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
Application #
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Eggers, Paul Wayne
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Tufts University
United States
Zip Code
Qian, K P; Natov, S N; Pereira, B J et al. (2000) Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat 7:153-60
Natov, S N; Lau, J Y; Ruthazer, R et al. (1999) Hepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study Group. Kidney Int 56:700-6
Natov, S N; Lau, J Y; Bouthot, B A et al. (1998) Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. Am J Kidney Dis 31:920-7
Pereira, B J; Natov, S N; Bouthot, B A et al. (1998) Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 53:1374-81
Murthy, B V; Muerhoff, A S; Desai, S M et al. (1998) Predictors of GBV-C infection among patients referred for renal transplantation. Kidney Int 53:1769-74
Pereira, B J; Levey, A S (1997) Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 51:981-99
Bouthot, B A; Murthy, B V; Schmid, C H et al. (1997) Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. Transplantation 63:849-53
Murthy, B V; Muerhoff, A S; Desai, S M et al. (1997) GB hepatitis agent in cadaver organ donors and their recipients. Transplantation 63:346-51
Murthy, B V; Muerhoff, A S; Desai, S M et al. (1997) Impact of pretransplantation GB virus C infection on the outcome of renal transplantation. J Am Soc Nephrol 8:1164-73